Edgewise Therapeutics Inc (EWTX)

SG&A Expenses

$47.62M

TTM · Period ending: · USD

EWTX logo

EWTX SG&A Expenses

Latest reported$47.62M
EWTX TTM SG&A Expenses ($2.21M → $47.62M)
High-resolution chart · PNG

EWTX sg&a expenses history

Trailing twelve months (TTM) · USD. Each value covers four complete reported quarters.

Edgewise Therapeutics Inc SG&A Expenses — Trailing twelve months (TTM) (USD)
Period endingSG&A Expenses (USD)
47,622,000
42,279,000
40,017,000
36,802,000
35,634,000
34,009,000
31,866,000
28,874,000
26,330,000
24,683,000
23,452,000
22,741,000
21,443,000
19,752,000
17,626,000
15,893,000
14,721,000
13,231,000
11,026,000
8,497,000
5,706,000
3,425,000
2,209,000
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.